Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3t42 | 3T4 | Aldose reductase | 1.1.1.21 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3t42 | 3T4 | Aldose reductase | 1.1.1.21 | 1.000 | |
2dv0 | ZST | Aldose reductase | 1.1.1.21 | 0.675 | |
1t41 | ID5 | Aldose reductase | 1.1.1.21 | 0.673 | |
1z3n | 3NA | Aldose reductase | 1.1.1.21 | 0.671 | |
3len | ZST | Aldose reductase | 1.1.1.21 | 0.665 | |
1t40 | ID5 | Aldose reductase | 1.1.1.21 | 0.663 | |
2fz9 | ZST | Aldose reductase | 1.1.1.21 | 0.660 | |
2ikj | 393 | Aldose reductase | 1.1.1.21 | 0.655 | |
2pdh | 47D | Aldose reductase | 1.1.1.21 | 0.655 | |
4gca | 2X9 | Aldose reductase | 1.1.1.21 | 0.655 | |
2pdu | 393 | Aldose reductase | 1.1.1.21 | 0.654 | |
2pdf | ZST | Aldose reductase | 1.1.1.21 | 0.649 | |
2dux | ZST | Aldose reductase | 1.1.1.21 | 0.647 | |
2hv5 | ZST | Aldose reductase | 1.1.1.21 | 0.645 | |
2hvo | ZST | Aldose reductase | 1.1.1.21 | 0.642 | |
3mb9 | ZST | Aldose reductase | 1.1.1.21 | 0.642 | |
1z89 | 62P | Aldose reductase | 1.1.1.21 | 0.641 | |
2pdm | ZST | Aldose reductase | 1.1.1.21 | 0.640 | |
2pdx | ZST | Aldose reductase | 1.1.1.21 | 0.640 | |
3m4h | 388 | Aldose reductase | 1.1.1.21 | 0.640 | |
3ghs | LDT | Aldose reductase | 1.1.1.21 | 0.634 | |
2hvn | ZST | Aldose reductase | 1.1.1.21 | 0.632 | |
3m64 | 393 | Aldose reductase | 1.1.1.21 | 0.632 | |
2pd5 | ZST | Aldose reductase | 1.1.1.21 | 0.630 | |
3lbo | LDT | Aldose reductase | 1.1.1.21 | 0.628 | |
2pdb | ZST | Aldose reductase | 1.1.1.21 | 0.625 | |
2pdp | 393 | Aldose reductase | 1.1.1.21 | 0.625 | |
2pzn | 393 | Aldose reductase | 1.1.1.21 | 0.624 | |
3g5e | Q74 | Aldose reductase | 1.1.1.21 | 0.624 | |
3lql | LDT | Aldose reductase | 1.1.1.21 | 0.623 | |
4yu1 | 53N | Aldose reductase | 1.1.1.21 | 0.621 | |
3ghr | LDT | Aldose reductase | 1.1.1.21 | 0.616 | |
3ght | LDT | Aldose reductase | 1.1.1.21 | 0.614 | |
2fz8 | ZST | Aldose reductase | 1.1.1.21 | 0.613 | |
2pdg | 47D | Aldose reductase | 1.1.1.21 | 0.613 | |
2qxw | LDT | Aldose reductase | 1.1.1.21 | 0.609 | |
3ld5 | LDT | Aldose reductase | 1.1.1.21 | 0.609 | |
1frb | ZST | Aldose reductase-related protein 2 | / | 0.608 | |
2duz | ZST | Aldose reductase | 1.1.1.21 | 0.608 | |
3ghu | LDT | Aldose reductase | 1.1.1.21 | 0.608 | |
3m0i | ZST | Aldose reductase | 1.1.1.21 | 0.607 | |
2pdi | ZST | Aldose reductase | 1.1.1.21 | 0.606 | |
3lz5 | LDT | Aldose reductase | 1.1.1.21 | 0.605 | |
2i16 | LDT | Aldose reductase | 1.1.1.21 | 0.603 | |
2i17 | LDT | Aldose reductase | 1.1.1.21 | 0.602 | |
1us0 | LDT | Aldose reductase | 1.1.1.21 | 0.600 | |
1pwl | BFI | Aldose reductase | 1.1.1.21 | 0.599 | |
2ikh | LIT | Aldose reductase | 1.1.1.21 | 0.597 | |
2pdq | 47D | Aldose reductase | 1.1.1.21 | 0.591 | |
2pdn | 47D | Aldose reductase | 1.1.1.21 | 0.585 | |
2iki | 388 | Aldose reductase | 1.1.1.21 | 0.582 | |
3mc5 | 393 | Aldose reductase | 1.1.1.21 | 0.574 | |
2pdc | 393 | Aldose reductase | 1.1.1.21 | 0.564 | |
1iei | ZES | Aldose reductase | 1.1.1.21 | 0.556 | |
2pdl | TOL | Aldose reductase | 1.1.1.21 | 0.551 | |
1zua | TOL | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.547 | |
2fzd | TOL | Aldose reductase | 1.1.1.21 | 0.542 | |
1ah3 | TOL | Aldose reductase | 1.1.1.21 | 0.540 | |
2pdj | 393 | Aldose reductase | 1.1.1.21 | 0.529 | |
4jsr | 1NQ | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.516 | |
3ny8 | JRZ | Beta-2 adrenergic receptor | / | 0.502 | |
2xup | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.500 | |
3n0h | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.497 | |
4b13 | X25 | Glycylpeptide N-tetradecanoyltransferase | / | 0.492 | |
3g49 | 3G4 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.489 | |
1ihi | IU5 | Aldo-keto reductase family 1 member C2 | / | 0.484 | |
2cbq | TH2 | Neocarzinostatin | / | 0.483 | |
4b11 | 7I1 | Glycylpeptide N-tetradecanoyltransferase | / | 0.483 | |
3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.482 | |
3k4s | 0MO | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.481 | |
3p2v | DOY | Aldose reductase | 1.1.1.21 | 0.481 | |
1el3 | I84 | Aldose reductase | 1.1.1.21 | 0.480 | |
3gsi | THG | Dimethylglycine oxidase | 1.5.3.10 | 0.480 | |
4eil | FOL | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.480 | |
4li8 | 1XQ | Tankyrase-1 | 2.4.2.30 | 0.480 | |
2y60 | M8F | Isopenicillin N synthase | 1.21.3.1 | 0.479 | |
2yne | YNE | Glycylpeptide N-tetradecanoyltransferase | / | 0.478 | |
4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.478 | |
3w5e | NVW | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.476 | |
1xf0 | ASD | Aldo-keto reductase family 1 member C3 | / | 0.474 | |
2aov | C2M | Histamine N-methyltransferase | 2.1.1.8 | 0.474 | |
2xuo | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.474 | |
4li6 | 1XO | Tankyrase-1 | 2.4.2.30 | 0.474 | |
1dgb | NDP | Catalase | 1.11.1.6 | 0.473 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.472 | |
3wd9 | QPC | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.472 | |
1p91 | SAM | 23S rRNA (guanine(745)-N(1))-methyltransferase | / | 0.471 | |
2bjs | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.471 | |
2hzq | STR | Apolipoprotein D | / | 0.471 | |
1i5r | HYC | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.470 | |
1lnm | DTX | Bilin-binding protein | / | 0.470 | |
4at4 | T6E | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.469 | |
4bvn | P32 | Beta-1 adrenergic receptor | / | 0.469 | |
4jtq | FLP | Aldo-keto reductase family 1 member C2 | / | 0.469 | |
4li7 | 1XP | Tankyrase-1 | 2.4.2.30 | 0.469 | |
2aot | 2PM | Histamine N-methyltransferase | 2.1.1.8 | 0.468 | |
4kq6 | DLZ | 6,7-dimethyl-8-ribityllumazine synthase | / | 0.468 | |
1nqv | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.467 | |
3zky | WT4 | Isopenicillin N synthase | 1.21.3.1 | 0.467 | |
4ky4 | 04J | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.467 | |
5jqh | CAU | Beta-2 adrenergic receptor | / | 0.467 | |
1tfz | 869 | 4-hydroxyphenylpyruvate dioxygenase | 1.13.11.27 | 0.466 | |
3pbl | ETQ | D(3) dopamine receptor | / | 0.466 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.465 | |
1zq5 | E04 | Aldo-keto reductase family 1 member C3 | / | 0.465 | |
3g4k | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.465 | |
2gvc | FAD | Thiol-specific monooxygenase | 1.14.13 | 0.464 | |
1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.463 | |
1rkw | PNT | HTH-type transcriptional regulator QacR | / | 0.463 | |
1uho | VDN | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.463 | |
1zgc | A2E | Acetylcholinesterase | 3.1.1.7 | 0.463 | |
2acl | L05 | Oxysterols receptor LXR-alpha | / | 0.463 | |
2xuh | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.463 | |
3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.463 | |
3jsx | CC2 | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.463 | |
4dbw | 511 | Aldo-keto reductase family 1 member C3 | / | 0.463 | |
1eve | E20 | Acetylcholinesterase | 3.1.1.7 | 0.462 | |
4bbh | YBN | Glycylpeptide N-tetradecanoyltransferase | / | 0.462 | |
4hyf | 1AK | Tankyrase-2 | 2.4.2.30 | 0.462 | |
4msk | 2C8 | Tankyrase-1 | 2.4.2.30 | 0.462 | |
1ut6 | A8N | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
1zgb | A1E | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
2pdk | SBI | Aldose reductase | 1.1.1.21 | 0.461 | |
2xui | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.461 | |
4jpg | 1OX | Pyruvate kinase PKM | 2.7.1.40 | 0.461 | |
5d6l | CAU | Beta-2 adrenergic receptor | / | 0.461 | |
1xon | PIL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.460 | |
2a59 | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.460 | |
2agt | FID | Aldose reductase | 1.1.1.21 | 0.460 | |
2f38 | 15M | Aldo-keto reductase family 1 member C3 | / | 0.460 | |
3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.460 | |
3wav | DWV | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 3.1.4.39 | 0.460 | |
4bj9 | UHB | Tankyrase-2 | 2.4.2.30 | 0.460 | |
1uk0 | FRM | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.459 | |
2cek | N8T | Acetylcholinesterase | 3.1.1.7 | 0.459 | |
2iqd | LPA | Aldose reductase | 1.1.1.21 | 0.459 | |
4dk7 | 0KS | Oxysterols receptor LXR-beta | / | 0.459 | |
4psb | GA3 | Cytokinin-specific binding protein | / | 0.459 | |
5fd8 | A5A | Putative carboxypeptidase yocD | / | 0.459 | |
1oyn | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
1q9m | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.458 | |
2a57 | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.458 | |
4gvs | F4M | Methenyltetrahydromethanopterin cyclohydrolase | 3.5.4.27 | 0.458 | |
4mm7 | 29J | Na(+):neurotransmitter symporter (Snf family) | / | 0.458 | |
1dgh | NDP | Catalase | 1.11.1.6 | 0.457 | |
1ry0 | PG2 | Aldo-keto reductase family 1 member C3 | / | 0.457 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.457 | |
2wu4 | HBP | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
2xug | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
2xuj | TZ5 | Acetylcholinesterase | 3.1.1.7 | 0.457 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.457 | |
4myq | 19T | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.457 | |
2f2k | TGG | Aldose reductase | 1.1.1.21 | 0.456 | |
3ch6 | 311 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.456 | |
3hxb | BD5 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.456 | |
3hxe | BD8 | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.456 | |
3t31 | DCQ | Sulfide-quinone reductase | / | 0.456 | |
4kn1 | 04J | Folate receptor beta | / | 0.456 | |
4mt9 | 2D6 | Tankyrase-1 | 2.4.2.30 | 0.456 | |
4u16 | 3C0 | Muscarinic acetylcholine receptor M3 | / | 0.456 | |
1pj7 | FFO | Dimethylglycine oxidase | 1.5.3.10 | 0.455 | |
2fzb | TOL | Aldose reductase | 1.1.1.21 | 0.455 | |
4fam | 0SZ | Aldo-keto reductase family 1 member C3 | / | 0.455 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.454 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.454 | |
4kn2 | LYA | Folate receptor beta | / | 0.454 | |
3o57 | ZG2 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.453 | |
3rj0 | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.453 | |
3vo2 | FAD | Ferredoxin--NADP reductase | / | 0.453 | |
2v2z | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | / | 0.452 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
2xuf | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
2xuq | TZ4 | Acetylcholinesterase | 3.1.1.7 | 0.452 | |
3g45 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.452 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
3g58 | 988 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
4b14 | 4XB | Glycylpeptide N-tetradecanoyltransferase | / | 0.452 | |
4c2z | 646 | Glycylpeptide N-tetradecanoyltransferase 1 | / | 0.452 | |
2ycx | P32 | Beta-1 adrenergic receptor | / | 0.452 | |
5a8e | XTK | Beta-1 adrenergic receptor | / | 0.452 | |
1kyv | RBF | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.451 | |
1u65 | CP0 | Acetylcholinesterase | 3.1.1.7 | 0.451 | |
1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.451 | |
2aou | CQA | Histamine N-methyltransferase | 2.1.1.8 | 0.451 | |
2c1z | KMP | Anthocyanidin 3-O-glucosyltransferase 2 | 2.4.1.115 | 0.451 | |
2vt4 | P32 | Beta-1 adrenergic receptor | / | 0.451 | |
3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.451 | |
4phl | PIL | Phosphodiesterase | / | 0.451 | |
1zkn | IBM | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
2iya | ZIO | Oleandomycin glycosyltransferase | / | 0.450 | |
2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
2psj | CEI | Renilla-luciferin 2-monooxygenase | 1.13.12.5 | 0.450 | |
3g4l | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.450 | |
4hlm | 16S | Tankyrase-2 | 2.4.2.30 | 0.450 | |
4lsa | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.450 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
3nhp | HGZ | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.449 | |
3sfh | 1DI | Histone deacetylase 8 | 3.5.1.98 | 0.449 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
4b65 | NDP | L-ornithine N(5)-monooxygenase | / | 0.449 | |
4bjb | P34 | Tankyrase-2 | 2.4.2.30 | 0.449 | |
4e0u | 0MV | Cyclic dipeptide N-prenyltransferase | / | 0.449 | |
4e2y | JHZ | Methyltransferase | / | 0.449 | |
4h7c | 10H | Aldo-keto reductase family 1 member C3 | / | 0.449 | |
4jt8 | 1NR | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.449 | |
4kmz | FOL | Folate receptor beta | / | 0.449 | |
1m9h | NAD | 2,5-diketo-D-gluconic acid reductase A | 1.1.1.346 | 0.448 | |
1s2c | FLF | Aldo-keto reductase family 1 member C3 | / | 0.448 | |
2j3q | TFL | Acetylcholinesterase | 3.1.1.7 | 0.448 | |
4a31 | 2CB | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
4e90 | 7RG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.448 | |
4gtr | 7TR | Protein farnesyltransferase subunit beta | 2.5.1.58 | 0.448 | |
4hcy | 0YN | Transketolase | / | 0.448 | |
1hqt | NAP | Alcohol dehydrogenase [NADP(+)] | 1.1.1.2 | 0.447 | |
2oaz | I96 | Methionine aminopeptidase 2 | / | 0.447 | |
3a1l | 2CC | Cytochrome P450 | / | 0.447 | |
3zec | ANP | Adenosine monophosphate-protein transferase SoFic | 2.7.7.n1 | 0.447 | |
4arb | C57 | Acetylcholinesterase | 3.1.1.7 | 0.447 | |
4flk | Y10 | Methionine aminopeptidase 1 | / | 0.447 | |
4ga8 | SBI | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.447 | |
4j7h | TRH | PCZA361.3 | / | 0.447 | |
4n1f | CZH | Obelin | / | 0.447 | |
4nqg | CZH | Mitrocomin | / | 0.447 | |
1bk0 | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
1kyx | CRM | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.446 | |
1s9d | AFB | Cytohesin-2 | / | 0.446 | |
1s9d | AFB | ADP-ribosylation factor 1 | / | 0.446 | |
1x8l | OXR | Retinol dehydratase | / | 0.446 | |
1y2k | 7DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
3mau | EXT | Putative sphingosine-1-phosphate lyase | / | 0.446 | |
3sl8 | JN7 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
4jt9 | 1NS | NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 3.5.1 | 0.446 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
4zzi | 1NS | NAD-dependent protein deacetylase sirtuin-1 | 3.5.1 | 0.446 | |
2ycy | P32 | Beta-1 adrenergic receptor | / | 0.446 | |
5d5a | CAU | Beta-2 adrenergic receptor | / | 0.446 | |
3uon | QNB | Muscarinic acetylcholine receptor M2 | / | 0.446 | |
1hb3 | SCV | Isopenicillin N synthase | 1.21.3.1 | 0.445 | |
1isg | AGS | ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 | 3.2.2.6 | 0.445 | |
1kms | LIH | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
1w6j | R71 | Lanosterol synthase | 5.4.99.7 | 0.445 | |
1y2d | 4DE | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.445 | |
2jf6 | S55 | Strictosidine-O-beta-D-glucosidase | 3.2.1.105 | 0.445 | |
2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
3dr7 | GPD | GDP-perosamine synthase | / | 0.445 | |
4bfy | ZVY | Pantothenate kinase | 2.7.1.33 | 0.445 | |
4dbu | BT9 | Aldo-keto reductase family 1 member C3 | / | 0.445 | |
4f1l | 0RY | Poly [ADP-ribose] polymerase 14 | 2.4.2.30 | 0.445 | |
4hmn | 16J | Aldo-keto reductase family 1 member C3 | / | 0.445 | |
2b01 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.444 | |
2zit | NAD | Exotoxin A | 2.4.2.36 | 0.444 | |
3q9b | B3N | Acetylpolyamine amidohydrolase | / | 0.444 | |
3x04 | GNP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.444 | |
4ara | C56 | Acetylcholinesterase | 3.1.1.7 | 0.444 | |
4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.444 | |
4jqa | ID8 | Aldo-keto reductase family 1 member C2 | / | 0.444 | |
1udt | VIA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.443 | |
1ygj | RMC | Pyridoxal kinase | 2.7.1.35 | 0.443 | |
2ha6 | SCK | Acetylcholinesterase | 3.1.1.7 | 0.443 | |
2inz | OHP | Aldose reductase | 1.1.1.21 | 0.443 | |
3r43 | ID8 | Aldo-keto reductase family 1 member C3 | / | 0.443 | |
3x02 | 5GP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.443 | |
4jq1 | NPS | Aldo-keto reductase family 1 member C2 | / | 0.443 | |
5liu | 388 | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.443 | |
1esm | COA | Pantothenate kinase | 2.7.1.33 | 0.442 | |
1t47 | NTD | 4-hydroxyphenylpyruvate dioxygenase | 1.13.11.27 | 0.442 | |
2tpl | HPP | Tyrosine phenol-lyase | 4.1.99.2 | 0.442 | |
3ghw | GHW | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
3u2c | SUZ | Aldose reductase | 1.1.1.21 | 0.442 | |
4f0r | MTA | 5-methylthioadenosine/S-adenosylhomocysteine deaminase | / | 0.442 | |
4x3u | SVR | Chromobox protein homolog 7 | / | 0.442 | |
1ry8 | RUT | Aldo-keto reductase family 1 member C3 | / | 0.441 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.441 | |
2wey | EV1 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
2y0j | AXC | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
4gtv | 7TR | Geranylgeranyl transferase type-2 subunit beta | 2.5.1.60 | 0.441 | |
4ia0 | 5BB | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.441 | |
4wev | SUZ | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.441 | |
4gbr | CAU | Beta-2 adrenergic receptor | / | 0.441 | |
1g60 | SAM | Modification methylase MboII | 2.1.1.72 | 0.440 | |
1o6q | R17 | Squalene--hopene cyclase | 4.2.1.129 | 0.440 | |
1odc | A8B | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
1ohk | COP | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.440 | |
1rvv | INI | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.440 | |
2bfa | CB3 | Pteridine reductase 1 | 1.5.1.33 | 0.440 | |
2fm0 | M98 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
2g5w | 8PG | 12-oxophytodienoate reductase 3 | 1.3.1.42 | 0.440 | |
3dyl | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
3lz6 | A0D | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.440 | |
3wqm | B29 | Diterpene synthase | 3.1.7.8 | 0.440 | |
4a30 | QMI | Glycylpeptide N-tetradecanoyltransferase | / | 0.440 | |
4a86 | H35 | Major pollen allergen Bet v 1-A | / | 0.440 | |
4dbs | 0HV | Aldo-keto reductase family 1 member C3 | / | 0.440 | |
4ey7 | E20 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
4jq3 | ZOM | Aldo-keto reductase family 1 member C2 | / | 0.440 |